Register entryRepackager / relabeller
REESE CONSUMER HEALTH CORPORATION
- Registered sites
- 1
- Drug products
- 13
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
RelabellingRepackaging
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| REESE CONSUMER HEALTH CORPORATION | Cleveland, OHUnited States | Relabelling, Repackaging | 1518939 |
Catalogue
Marketed products
13Showing 13 of 13.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| CVS Health Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TABLET | UNAPPROVED DRUG OTHER |
| DG Health Immediate Release Mucus Relief | Guaifenesin | TABLET | OTC MONOGRAPH DRUG |
| Pinworm Medicine | PYRANTEL PAMOATE | SUSPENSION | OTC MONOGRAPH DRUG |
| Preferred Antibacterial Plus Urinary Pain Relief | METHENAMINE, SODIUM SALICYLATE | TABLET | UNAPPROVED DRUG OTHER |
| Preferred Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TABLET | UNAPPROVED DRUG OTHER |
| Preferred Stool Softener | DOCUSATE SODIUM | CAPSULE, LIQUID FILLED | OTC MONOGRAPH DRUG |
| Preferred Stool Softener | Docusate Calcium | CAPSULE, LIQUID FILLED | OTC MONOGRAPH DRUG |
| Preferred Stool Softener laxative | DOCUSATE SODIUM | CAPSULE, LIQUID FILLED | OTC MONOGRAPH DRUG |
| Preferred Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TABLET | UNAPPROVED DRUG OTHER |
| Reese Headache Powders | Aspirin and Caffeine | POWDER | OTC MONOGRAPH DRUG |
| Refenesen Mucus Relief | Guaifenesin | TABLET | OTC MONOGRAPH DRUG |
| Refenesen Mucus Relief DM | Dextromethorphan Hydrobromide / Guaifenesin | TABLET | OTC MONOGRAPH DRUG |
| Vexia Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TABLET | UNAPPROVED DRUG OTHER |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.